Siglec-15 is a glyco-immune checkpoint in prostate cancer regulating immune evasion and metastasis

Matthews, N. et al.

bioRxiv / medRxiv · Papers · License: Open Access

cancer biology

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 668726
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.